Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of senescence-related genes in polycystic ovary syndrome. | J Ovarian Res | 2024 | 38184636 | PubTator, text mining | PubMed |
| Bioengineered MSCGFPCxcr2-Mmp13 Transplantation Alleviates Hepatic Fibrosis by Regulating Mammalian Target of Rapamycin Signaling. | Antioxid Redox Signal | 2024 | 38183635 | PubTator, text mining | PubMed |
| Single-cell analysis reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of ovarian cancer. | Commun Biol | 2024 | 38182756 | PubTator, text mining | PubMed |
| BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer. | Cell Death Discov | 2024 | 38182557 | PubTator, text mining | PubMed |
| Systematic analysis of the prognostic value and immunological function of LTBR in human cancer. | Aging (Albany NY) | 2024 | 38175686 | PubTator, text mining | PubMed |
| Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy. | Eur J Med Res | 2024 | 38173048 | PubTator, text mining | PubMed |
| A novel prognostic predictor of immune microenvironment and therapeutic response in clear cell renal cell carcinoma based on angiogenesis-immune-related gene signature. | Heliyon | 2024 | 38170124 | PubTator, text mining | PubMed |
| LncRNA CRNDE Drives the Progression of Hepatocellular Carcinoma by inducing the Immunosuppressive Niche. | Int J Biol Sci | 2024 | 38169579 | PubTator, text mining | PubMed |
| [Progress of Immunotherapy in EGFR-mutated Advanced Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2024 | 38163979 | PubTator, text mining | PubMed |
| Integrative analysis reveals chemokines CCL2 and CXCL5 mediated shear stress-induced aortic dissection formation. | Heliyon | 2024 | 38163105 | PubTator, text mining | PubMed |
| BMP4 up-regulated by 630 nm LED irradiation is associated with the amelioration of rheumatoid arthritis. | J Photochem Photobiol B | 2024 | 38101122 | PubTator, text mining | PubMed |
Transcriptional profiling of human peripheral blood mononuclear cells in household contacts of pulmonary tuberculosis patients provides insights into mechanisms of Mycobacterium tuberculosis control and elimination. | Emerg Microbes Infect | 2024 | 38088554 | PubTator, text mining | PubMed |
| Multi-omics analyses reveal bacteria and catalase associated with keloid disease. | EBioMedicine | 2024 | 38061241 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa. | J Clin Invest | 2024 | 38051587 | PubTator, text mining | PubMed |
| Cancer Evolution: A Multifaceted Affair. | Cancer Discov | 2024 | 38047596 | PubTator, text mining | PubMed |
| Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy. | Br J Cancer | 2024 | 38040818 | PubTator, text mining | PubMed |
| Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies. | Chin Med J (Engl) | 2024 | 38031348 | PubTator, text mining | PubMed |
| Global Transcriptome Analysis Reveals Distinct Phases of the Endothelial Response to TNF. | J Immunol | 2024 | 38019121 | PubTator, text mining | PubMed |
| STK11 loss leads to YAP1-mediated transcriptional activation in human KRAS-driven lung adenocarcinoma cell lines. | Cancer Gene Ther | 2024 | 37968341 | PubTator, text mining | PubMed |
| Critical role of CD206+ macrophages in promoting a cDC1-NK-CD8 T cell anti-tumor immune axis. | bioRxiv | 2024 | 37961697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=12